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HECW1 (aka (HECT, C2 And WW Domain Containing 
E3 Ubiquitin Protein Ligase 1) is an E3 ubiquitin      
protein ligase that mediates ubiquitination and       
subsequent degradation of DVL1 (Dishevelled      
Segment Polarity Protein 1). DVL1 encodes a          
cytoplasmic phosphoprotein that regulates cell        
proliferation. 
    HECW1 also targets the mutant SOD1 (Superoxide 
Dismutase 1) protein involved in motor neuron death 
in Familial Amyotrophic Lateral Sclerosis (FALS).
     In cancer, HECW1 promotes the proliferation,            
migration and invasion of non-small cell lung cancer 
cells by inducing the ubiquitination and degradation of 
Smad4 (Smad proteins act as a tumor suppressors 
and inhibits epithelial cell proliferation). 
Figure 6: HECW1 C-lobe is active. Alexa Fluor 647 
ubiquitin assay that shows wildtype HECW1 C-lobe 
(lane 8) can form an E3 ligase.  Samples were run 
on a 15% Bis-Tris polyacrcylamide gel and visual-
ized using iBright imaging.  
Figure 1: FALS in a patient. A main symptom of FALS is a 
curvature of the spine.
Image obtained from: Wokke, J., et al. Cambridge University Press. 
doi:10.1017/CBO9780511735905.003
igure 2: Ubiquitin E3 pathway. Ubiquitin (in yellow) is 
assed  between E1 (in navy), E2 (in purple), and E3 (RING 
n black; HECT in green) enzymes. It forms an isopeptide 
ond between the C-terminus of Ub and the e-amino group 
f lysine on a substrate protein.
Figure 4: SDS gel filtrations from Day one and Day two of purification. (A) 
Day one shows a pure Flowthrough (F1) and Elute (E1). (B) Day two 






Figure 5:  AKTA purification analysis.  (A) Blue curve shows pure 
protein fractions (T14-24). (B) SDS gel filtration of protein fractions 
T14-24 show that 18, 20, and 22 are the most pure.
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Figure 3: A diagram of the purification protocol. First, IPTG induced cells are 
spun down at 10,000rpm for 10 minutes, then are lysed via homogenization. 
The lysed cells are ultracentrifuged where they are then proteins are isolated 
via Nickel chromatography. This yields Flowthrough and Elution 1. The elu-
tion has TEV added where it is put in dialysis overnight. The next day, the 
His6 tag is removed via nickel chromatography to get Flowthrough and Elu-
tion 2. All four proteins are then analyzed on SDS-PAGE, and other analyses 
can be done.
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